
|Podcasts|May 30, 2023
Health Equity Isn't a Theme, It's a Long-term Commitment
Advertisement
Wizdom Powell, PhD, MPH
Geetha Achanta, Scientific Director at OncLive
Tyrone Brewer, president of Janssen US Oncology
The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO 2022) focused on health equity. Even though it’s not this year’s theme for ASCO, at Janssen, health equity remains our focus year-round. Consistent commitment is how we achieve lasting systemic change. We must work together as a health care system – including pharma, health care practitioners (HCPs), payors, and more – to tackle the inherent biases in our care system, break down barriers to access, and build trust.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5






























